Please login to the form below

Not currently logged in
Email:
Password:

2013 trends

This page shows the latest 2013 trends news and features for those working in and with pharma, biotech and healthcare.

Technology trends facing pharma in 2013

Technology trends facing pharma in 2013

Context-based services and social media are among the major technology trends pharma will need to embrace in 2013. ... The management consulting company identified six cross-industry technology trends that will influence companies over the next three to

Latest news

More from news
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest Intelligence

  • Inside: CROs (2013/2014) Inside: CROs (2013/2014)

    Your guide to contract research trends. The 2013/2014 edition of Inside: CROs taking the pulse of contract research sector, casting an expert eye over 12 months that have seen the ... With the pressure on for biopharma companies to radically improve the

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

  • Indigenus eyeforpharma 2013

    The Indigenus take of eyeforpharma - interviews with Florian Bernsdrof (Indigenus co-Chairman and Indigenus Germany), Matthieu Blanchais (from Indigenus France) and Xavi Sánchez (from Indigenus Spain) along side Thushani Kumarasinghe (vp of

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Wisepress

Wisepress is a medical bookseller promoting and selling books worldwide, both online and via the 200 European medical conferences that...

Latest intelligence

Virtual meeting technologies for reducing emissions and waste in the healthcare industry
...
Diversity in clinical trials: looking back at our 2021 blogs
In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021...
What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...